BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27734403)

  • 1. Method for Analysis of Matrix Degradation by CCN2 Through the MMP/TIMP System.
    McLennan SV; Min D; Wang X; Twigg SM
    Methods Mol Biol; 2017; 1489():523-532. PubMed ID: 27734403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of TIMPs in regulation of extracellular matrix proteolysis.
    Arpino V; Brock M; Gill SE
    Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts.
    Bai G; Howell DS; Howard GA; Roos BA; Cheung HS
    Osteoarthritis Cartilage; 2001 Jul; 9(5):416-22. PubMed ID: 11467889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
    J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation.
    Badier-Commander C; Verbeuren T; Lebard C; Michel JB; Jacob MP
    J Pathol; 2000 Sep; 192(1):105-12. PubMed ID: 10951407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y; Koda M; Murawaki Y
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of matrix metalloproteinase (MMP) and tissue inhibitor of matrix metalloproteinase (TIMP) genes during JHMV infection of the central nervous system.
    Zhou J; Stohlman SA; Marten NW; Hinton DR
    Adv Exp Med Biol; 2001; 494():329-34. PubMed ID: 11774488
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method.
    Higashikata T; Yamagishi M; Higashi T; Nagata I; Iihara K; Miyamoto S; Ishibashi-Ueda H; Nagaya N; Iwase T; Tomoike H; Sakamoto A
    Atherosclerosis; 2006 Mar; 185(1):165-72. PubMed ID: 16039658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP.
    Becher N; Hein M; Uldbjerg N; Danielsen CC
    Reprod Biol Endocrinol; 2008 Sep; 6():45. PubMed ID: 18826601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drusen are Cold Spots for Proteolysis: Expression of Matrix Metalloproteinases and Their Tissue Inhibitor Proteins in Age-related Macular Degeneration.
    Leu ST; Batni S; Radeke MJ; Johnson LV; Anderson DH; Clegg DO
    Exp Eye Res; 2002 Jan; 74(1):141-54. PubMed ID: 11878827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases: pathways of induction by bioactive molecules.
    Tsuruda T; Costello-Boerrigter LC; Burnett JC
    Heart Fail Rev; 2004 Jan; 9(1):53-61. PubMed ID: 14739768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
    Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
    J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
    Hoheisel G; Sack U; Hui DS; Lai F; Chan KS; Choi CH; Schauer J; Tannapfel A
    Pneumologie; 2004 May; 58(5):305-8. PubMed ID: 15162254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan.
    Aoyama E; Hattori T; Hoshijima M; Araki D; Nishida T; Kubota S; Takigawa M
    Biochem J; 2009 May; 420(3):413-20. PubMed ID: 19298220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases systems and autoantibody patterns in systemic sclerosis.
    Montagnana M; Volpe A; Lippi G; Caramaschi P; Salvagno GL; Biasi D; Bambara LM; Guidi GC
    Clin Biochem; 2007 Aug; 40(12):837-42. PubMed ID: 17493602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in matrix metalloproteinase research.
    Murphy G; Nagase H
    Mol Aspects Med; 2008 Oct; 29(5):290-308. PubMed ID: 18619669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
    Shukla V; Kumar Shakya A; Dhole TN; Misra UK
    Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.